trans-4-Methoxycyclohexanamine

Catalog No. :
ACRUIE835
CAS No. :
121588-79-2
Molecular Formula :
C7H15NO
Molecular Weight :
129.20

IUPAC Name:(1r,4r)-4-methoxycyclohexan-1-amine

trans-4-Methoxycyclohexanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$126.00Login to see priceIn stockIn stock
25g98%$562.00Login to see priceIn stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametrans-4-Methoxycyclohexanamine
IUPAC Name(1r,4r)-4-methoxycyclohexan-1-amine
MDL No.MFCD20278175
Molecular FormulaC7H15NO
Molecular Weight129.20
SMILESN[C@H]1CC[C@H](OC)CC1
InChI KeySDMXLAZIFYYECU-LJGSYFOKSA-N
SynonymMFCD18207818 | AMY21463 | SB31854 | (1s,4s)-4-methoxycyclohexan-1-amine | BB 0261291 | SCHEMBL3539502 | Cyclohexanamine, 4-methoxy-, trans- | BB 0261292 | SY012780 | MFCD20278175 | A932270 | DS-17021 | EN300-251636 | SDMXLAZIFYYECU-LJGSYFOKSA-N | (cis-4-M
CAS No.121588-79-2
PubChem CID409910

Safety Data

Pictogram
FlammableCorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H226-H302-H314-H335
Precautionary Statement(s)
P210-P240-P241-P242-P243-P260-P264-P270-P271-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P370+P378-P403+P233-P403+P235-P405-P501

Synthetic Route by SureRoute

1. ACRUIE835 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRUIE835 route product structure diagram
    ACRUIE835121588-79-2 In Stock
Inquiry

2. ACRUIE835 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACRUIE835 route product structure diagram
    ACRUIE835121588-79-2 In Stock
Inquiry

Comments (0)